TMEM97 and cancer: S2Ris a poorly understood protein whose identification dates to1990, which has attracted considerable interest as target for thetreatment of neurological diseases and cancer.15 In 2017, S2R was identified as an endoplasmic reticulum-residenttransmembrane protein (TMEM97).